Anteris Technologies Global Corp. 8-K

What Happened

• On January 22, 2026, Anteris Technologies Global Corp. and Medtronic plc issued a joint press release announcing a strategic investment by Medtronic (through a wholly owned subsidiary) in Anteris.
• The investment is being made pursuant to a stock purchase agreement dated January 20, 2026. The press release was attached to the Form 8-K as Exhibit 99.1 and reported under Item 7.01 (Regulation FD Disclosure).

Key Details

• Press release date: January 22, 2026 (joint announcement by Anteris and Medtronic).
• Stock purchase agreement date: January 20, 2026, between Anteris and a wholly owned subsidiary of Medtronic.
• Filing: Reported on Form 8-K under Item 7.01; the joint press release is filed as Exhibit 99.1.
• The Form 8-K does not disclose investment amount, share counts, or other financial terms—refer to the attached press release for further specifics.

Why It Matters

• A strategic investment from Medtronic, a major medical device company, is a material corporate development that could affect Anteris’s capital structure, partnerships, and market perception.
• Because the 8-K and exhibit do not include transaction economics or timing, investors should review the attached press release and any future filings for details on terms, dilution, regulatory approvals, or timing that could impact valuation or operations.